The use of dry powder inhaler devices by elderly patients suffering from chronic obstructive pulmonary disease

Ann Phys Rehabil Med. 2010 Mar;53(2):69-76. doi: 10.1016/j.rehab.2009.11.001. Epub 2009 Dec 1.
[Article in English, French]

Abstract

Twenty-five COPD patients, aged 65years or above, were recruited to test their ability to use dry powder inhaler Handihaler (Boeringher-Ingelheim) and Aerolizer (Novartis). The results of a score created to evaluate the inhalation technique were compared with age, MMSE, Barthel Index, FEV(1), maximum inspiratory and expiratory pressures, and peak inspiratory flow (PIF).

Results: Dry powder inhalers were correctly used by 60% of the patients (15 out of 25). Among the capable ones, 13 out of 15 were aged less than 80 years (p< or =0.02), 13 out of 15 had a maximum inspiratory pressure greater or equal to 53cm H(2)O (p< or =0.001) and a PIF greater or equal to 120l/min (p< or =0.05). All skilled patients had a minimum MMSE of 25 (p< or =0.001).

Conclusion: In a geriatric population, age, the decrease of maximum inspiratory pressure and PIF as well as cognitive functions, limit the use of dry powder inhalers.

Publication types

  • Clinical Trial

MeSH terms

  • Administration, Inhalation
  • Aged
  • Aged, 80 and over
  • Cognition Disorders / complications
  • Equipment Design
  • Female
  • Humans
  • Male
  • Mental Competency
  • Nebulizers and Vaporizers*
  • Patient Education as Topic
  • Powders
  • Psychomotor Performance*
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Pulmonary Disease, Chronic Obstructive / psychology
  • Respiratory Function Tests

Substances

  • Powders